ICD 10 CM E11.3413 | Description & Clinical Information

ICD 10 E11.3413 describes a medical condition characterized by the body’s inability to produce or use insulin effectively, resulting in high levels of blood glucose, along with severe nonproliferative diabetic retinopathy (NPDR) affecting both eyes, which is marked by the presence of dot hemorrhages, microaneurysms, and intraretinal microvascular abnormalities, and macular edema, which is the swelling of the macula, the area of the retina responsible for sharp vision.

Official Description Of E11.3413

The ICD 10 CM book defines ICD 10 code E11.3413 as:

When To Use E11.3413

The diagnosis describes by the ICD 10 CM E11.3413 code is a medical condition known as Non-Proliferative Diabetic Retinopathy (NPDR). This condition affects the retina and is characterized by the appearance of lesions such as small dot and blot hemorrhages, splinter hemorrhages, and intraretinal microvascular abnormalities. These lesions, which are confined to the retina, can determine the severity of the condition. Mild, moderate, or severe qualities of NPDR can be present in individuals, with the severity depending on the severity of the lesions. In individuals with severe NPDR, there are dot hemorrhages, microaneurysms, venous beading, and intraretinal microvascular abnormalities in various quadrants of the eye. This can lead to visual problems and, if left uncontrolled, can cause serious complications such as retinal detachment.

Patients with type 2 diabetes are at high risk of developing NPDR. In addition to the specific symptoms of NPDR, general symptoms of type 2 diabetes may also be present, such as extreme thirst, hunger, fatigue, and frequent infections. To diagnose NPDR in individuals with a history of type 2 diabetes, providers typically perform a complete physical and eye examination. This includes the performance of laboratory tests such as blood tests that measure glucose levels, lipid profiles, and HbA1C levels, as well as urine tests for albumin, ketones, and glucose. In some cases, fluorescence angiography may also be performed to assess the condition of the patient’s retinal vasculature.

Treatment for NPDR may depend on the severity of the condition. In mild cases, the focus of treatment may be on lifestyle changes such as a healthy diet, exercise, and weight management. Laser photocoagulation treatment may be recommended to address lesions such as dot hemorrhages, microaneurysms, and intraretinal microvascular abnormalities in moderate to severe cases. Steroids may be prescribed to reduce inflammation and macular edema. In some cases, surgery may also be necessary to reduce intraocular pressure or correct nerve damage.

For patients with type 2 diabetes, oral drug therapy is typically used to improve glycemic control and prevent subsequent complications. In severe cases, insulin may be necessary depending on the patient’s blood glucose levels. Blood glucose levels must be closely monitored during treatment to ensure that the patient’s condition does not worsen.

In summary, the diagnosis of NPDR described by the ICD 10 CM E11.3413 code is a potentially serious condition that can develop in individuals with type 2 diabetes. While the diagnostic process can involve laboratory tests and imaging studies, a clinical examination is essential for detecting the presence of the specific lesions. Treatment can involve various approaches and should be individualized based on the severity of the condition. In addition, management of type 2 diabetes is an essential component of NPDR treatment, with lifestyle changes and medication management playing critical roles in preventing further complications.